| 1 | A rare concurrence: nonischemic cardiomyopathy and multiple myeloma without amyloidosis. (Gupta T, Garg J, Sharma M, Khera S, Kolte D, Aronow WS, Frishman WH, Lanier GM) Am J Med 2014 Nov;127(11):1063-6 1 Citation |
| 2 | Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. (Chandran K, Aggarwal D, Migrino RQ, Joseph J, McAllister D, Konorev EA, Antholine WE, Zielonka J, Srinivasan S, Avadhani NG, Kalyanaraman B) Biophys J 2009 Feb 18;96(4):1388-98 114 Citations |
| 1 | Case report: Delayed enhancement on cardiac MRI in a patient with multiple myeloma without amyloidosis. (Brahmbhatt T, Hari P, Cinquegrani M, Kumar N, Komorowski R, Migrino RQ) Br J Radiol 2008 Nov;81(971):e272-5 5 Citations |
| 1 | Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. (Jahanyar J, Joyce DL, Southard RE, Loebe M, Noon GP, Koerner MM, Torre-Amione G, Youker KA) J Heart Lung Transplant 2007 Jan;26(1):34-40 30 Citations |
| 1 | Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. (Huentelman MJ, Grobe JL, Vazquez J, Stewart JM, Mecca AP, Katovich MJ, Ferrario CM, Raizada MK) Exp Physiol 2005 Sep;90(5):783-90 164 Citations |
